{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "COVID-19", "Coronavirus", "Limonoids", "Molecular docking", "Triterpenoids"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32738628", "DateCompleted": {"Year": "2020", "Month": "09", "Day": "24"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1016/j.compbiomed.2020.103936", "S0010-4825(20)30272-9"], "Journal": {"ISSN": "1879-0534", "JournalIssue": {"Volume": "124", "PubDate": {"Year": "2020", "Month": "Sep"}}, "Title": "Computers in biology and medicine", "ISOAbbreviation": "Comput Biol Med"}, "ArticleTitle": "In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.", "Pagination": {"StartPage": "103936", "MedlinePgn": "103936"}, "Abstract": {"AbstractText": ["Virtual screening of phytochemicals was performed through molecular docking, simulations, in silico ADMET and drug-likeness prediction to identify the potential hits that can inhibit the effects of SARS-CoV-2. Considering the published literature on medicinal importance, 154 phytochemicals with analogous structure from limonoids and triterpenoids were selected to search potential inhibitors for the five therapeutic protein targets of SARS-CoV-2, i.e., 3CLpro (main protease), PLpro (papain-like protease), SGp-RBD (spike glycoprotein-receptor binding domain), RdRp (RNA dependent RNA polymerase) and ACE2 (angiotensin-converting enzyme 2). The in silico computational results revealed that the phytochemicals such as glycyrrhizic acid, limonin, 7-deacetyl-7-benzoylgedunin, maslinic acid, corosolic acid, obacunone and ursolic acid were found to be effective against the target proteins of SARS-CoV-2. The protein-ligand interaction study revealed that these phytochemicals bind with the amino acid residues at the active site of the target proteins. Therefore, the core structure of these potential hits can be used for further lead optimization to design drugs for SARS-CoV-2. Also, the medicinal plants containing these phytochemicals like licorice, neem, tulsi, citrus and olives can be used to formulate suitable therapeutic approaches in traditional medicines."], "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry, S.V. National Institute of Technology (SVNIT), Surat, 395007, Gujarat, India."}], "LastName": "Vardhan", "ForeName": "Seshu", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Chemistry, S.V. National Institute of Technology (SVNIT), Surat, 395007, Gujarat, India. Electronic address: sks@chem.svnit.ac.in."}], "LastName": "Sahoo", "ForeName": "Suban K", "Initials": "SK"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Comput Biol Med", "NlmUniqueID": "1250250", "ISSNLinking": "0010-4825"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Limonins"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Nonstructural Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "EC 2.7.7.48", "NameOfSubstance": "Coronavirus RNA-Dependent RNA Polymerase"}, {"RegistryNumber": "EC 2.7.7.48", "NameOfSubstance": "NSP12 protein, SARS-CoV-2"}, {"RegistryNumber": "EC 2.7.7.48", "NameOfSubstance": "RNA-Dependent RNA Polymerase"}, {"RegistryNumber": "EC 3.4.15.1", "NameOfSubstance": "Peptidyl-Dipeptidase A"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "ACE2 protein, human"}, {"RegistryNumber": "EC 3.4.17.23", "NameOfSubstance": "Angiotensin-Converting Enzyme 2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Angiotensin-Converting Enzyme 2"}, {"QualifierName": ["chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["chemistry", "drug effects"], "DescriptorName": "Betacoronavirus"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Computational Biology"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Coronavirus Infections"}, {"QualifierName": [], "DescriptorName": "Coronavirus RNA-Dependent RNA Polymerase"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["drug effects"], "DescriptorName": "Host Microbial Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Limonins"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": ["chemistry", "drug effects"], "DescriptorName": "Peptidyl-Dipeptidase A"}, {"QualifierName": ["chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["drug therapy", "virology"], "DescriptorName": "Pneumonia, Viral"}, {"QualifierName": ["chemistry", "drug effects"], "DescriptorName": "RNA-Dependent RNA Polymerase"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["chemistry", "drug effects"], "DescriptorName": "Spike Glycoprotein, Coronavirus"}, {"QualifierName": ["chemistry", "pharmacokinetics", "pharmacology"], "DescriptorName": "Triterpenes"}, {"QualifierName": ["chemistry", "drug effects"], "DescriptorName": "Viral Nonstructural Proteins"}, {"QualifierName": ["chemistry", "drug effects"], "DescriptorName": "Viral Proteins"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Guo Y.-R., Cao Q.-D. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status. Mil. Med. Res. 2020;7:11.", "ArticleIdList": ["PMC7068984", "32169119"]}, {"Citation": "Coronavirus Disease (COVID-2019) Situation Reports-165, 3rd July 2020. World Health Organization; 2020."}, {"Citation": "https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2."}, {"Citation": "Zhou Y. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020;6:14.", "ArticleIdList": ["PMC7073332", "32194980"]}, {"Citation": "Singh A. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: a systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab. Syndr. 2020;14:241\u2013246.", "ArticleIdList": ["PMC7102587", "32247211"]}, {"Citation": "Zhu Z. Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19. J. Infect. 2020;81:e21\u2013e23.", "ArticleIdList": ["PMC7195393", "32283143"]}, {"Citation": "Choy K. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antivir. Res. 2020;178:104786.", "ArticleIdList": ["PMC7127386", "32251767"]}, {"Citation": "Dong L. Discovering drugs to treat coronavirus disease 2019 (COVID-19) Drug Discov. Ther. 2020;14:58\u201360.", "ArticleIdList": ["32147628"]}, {"Citation": "McKee D. Candidate drugs against SARS-CoV-2 and COVID-19. Pharmacol. Res. 2020;157:104859.", "ArticleIdList": ["PMC7189851", "32360480"]}, {"Citation": "Yang Y. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int. J. Biol. Sci. 2020;16:1708\u20131717.", "ArticleIdList": ["PMC7098036", "32226288"]}, {"Citation": "Liu M. Efficacy and safety of integrated traditional Chinese and western medicine for corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. Pharmacol. Res. 2020;158:104896.", "ArticleIdList": ["PMC7211759", "32438037"]}, {"Citation": "Ho L.T.F. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19. Eur. J. Integr. Med. 2020;36:101116.", "ArticleIdList": ["PMC7129866", "32292529"]}, {"Citation": "Ryu Y.B. SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii. Bioorg. Med. Chem. Lett. 2010;20:1873\u20131876.", "ArticleIdList": ["PMC7127101", "20167482"]}, {"Citation": "Pillaiyar T. An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy. J. Med. Chem. 2016;59:6595\u20136628.", "ArticleIdList": ["PMC7075650", "26878082"]}, {"Citation": "Fuzimoto A.D. The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - additional weapons in the fight against the COVID-19 pandemic. J. Tradit. Complement. Med. 2020;10:405\u2013419.", "ArticleIdList": ["PMC7260130", "32691005"]}, {"Citation": "Fiore C., Eisenhut M., Krausse R. Antiviral effects of Glycyrrhiza species. Phytother Res. 2008;22:141\u2013148.", "ArticleIdList": ["PMC7167979", "17886224"]}, {"Citation": "Vardhan S., Sahoo S.K. 2020. Searching Inhibitors for Three Important Proteins of COVID-19 through Molecular Docking Studies. arXiv:2004.08095."}, {"Citation": "Wang H. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur. J. Clin. Microbiol. Infect. Dis. 2020 doi: 10.1007/s10096-020-03899-4.", "ArticleIdList": ["10.1007/s10096-020-03899-4", "PMC7180649", "32333222"]}, {"Citation": "Frisch M.J. Gaussian Incorp; Wallingford, CT: 2009. Gaussian 09W, Revision A.1."}, {"Citation": "Trott O., Vina AutoDock. Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2009:455\u2013461.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Jamroz M. CABS-flex predictions of protein flexibility compared with NMR ensembles. Bioinformatics. 2014;30:2150\u20132154.", "ArticleIdList": ["PMC4103595", "24735558"]}, {"Citation": "Pires D.E.V., Blundell T.L., Ascher D.B. pkCSM: predicting small-molecule pharmacokinetic properties using graph-based signatures. J. Med. Chem. 2015;58:4066\u20134072.", "ArticleIdList": ["PMC4434528", "25860834"]}, {"Citation": "https://www.sciencedirect.com/topics/immunology-and-microbiology/lipophilicity."}, {"Citation": "Xiao S. Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives. Med. Res. Rev. 2018;38:951\u2013976.", "ArticleIdList": ["PMC7168445", "29350407"]}, {"Citation": "Yuan Y. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat. Commun. 2017;8:15092.", "ArticleIdList": ["PMC5394239", "28393837"]}, {"Citation": "Guy J. Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J. 2005;272:3512\u20133520.", "ArticleIdList": ["PMC7164114", "16008552"]}, {"Citation": "Liu C. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent. Sci. 2020;6:315\u2013331.", "ArticleIdList": ["PMC10467574", "32226821"]}, {"Citation": "Kilianski A. Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. J. Virol. 2013;87:11955\u201311962.", "ArticleIdList": ["PMC3807373", "23986593"]}, {"Citation": "Shah B. In silico studies on therapeutic agents for COVID-19: drug repurposing approach. Life Sci. 2020;252:117652.", "ArticleIdList": ["PMC7194845", "32278693"]}, {"Citation": "Yu R. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. Int. J. Antimicrob. Agents. 2020 doi: 10.1016/j.ijantimicag.2020.106012.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.106012", "PMC7205718", "32389723"]}, {"Citation": "http://www.molinspiration.com/cgi-bin/properties."}, {"Citation": "Li J. Glycyrrhizic acid in the treatment of liver diseases: literature review. BioMed Res. Int. 2014:872139.", "ArticleIdList": ["PMC4052927", "24963489"]}, {"Citation": "Yap W. Mechanistic perspectives of maslinic acid in targeting inflammation. Biochem. Res. Int. 2015:279356.", "ArticleIdList": ["PMC4600485", "26491566"]}, {"Citation": "Graebin C. Glycyrrhizin and glycyrrhetic acid: scaffolds to promising new pharmacologically active compounds. J. Braz. Chem. Soc. 2010;21:1595\u20131615."}, {"Citation": "Abdelgaleil S.A. Antifungal limonoids from the fruits of Khaya senegalensis. Fitoterapia. 2004;75:566\u2013572.", "ArticleIdList": ["15351110"]}, {"Citation": "Parikh N.R. Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives. Phytochem. Rev. 2014;13:793\u2013810.", "ArticleIdList": ["PMC4225818", "25395898"]}, {"Citation": "Takagi M. Cytotoxic and melanogenesis-inhibitory activities of limonoids from the leaves of Azadirachta indica (neem) Chem. Biodivers. 2014;11:451\u2013468.", "ArticleIdList": ["24634075"]}, {"Citation": "Kikuchi T. Cytotoxic and apoptosis-inducing activities of limonoids from the seeds of Azadirachta indica (neem) J. Nat. Prod. 2011;74:866\u2013870.", "ArticleIdList": ["21381696"]}, {"Citation": "Thillainayagam M. Insights on inhibition of Plasmodium falciparum plasmepsin I by novel epoxyazadiradione derivatives \u2013 molecular docking and comparative molecular field analysis. J. Biomol. Struct. Dyn. 2018;37:3168\u20133182.", "ArticleIdList": ["30092746"]}, {"Citation": "Battinelli L. Effect of limonin and nomilin on HIV-1 replication on infected human mononuclear cells. Planta Med. 2003;69:910\u2013913.", "ArticleIdList": ["14648393"]}, {"Citation": "Miranda J\u00fanior R.N.C. Antiplasmodial activity of the andiroba (Carapa guianensis Aubl., Meliaceae) oil and its limonoid-rich fraction. J. Ethnopharmacol. 2012;142:679\u2013683.", "ArticleIdList": ["22659195"]}, {"Citation": "Laura C. Oleanolic acid: a promising neuroprotective agent for cerebral ischemia. Neural. Regen. Res. 2015;10:540\u2013541.", "ArticleIdList": ["PMC4424737", "26170805"]}, {"Citation": "Ramos-Hryb A.B. Therapeutic potential of ursolic acid to manage neurodegenerative and psychiatric diseases. CNS Drugs. 2017;31:1029\u20131041.", "ArticleIdList": ["29098660"]}, {"Citation": "Murthy K.N.C. Citrus limonin and its glucoside inhibit colon adenocarcinoma cell proliferation through apoptosis. J. Agric. Food Chem. 2011;59:2314\u20132323.", "ArticleIdList": ["21338095"]}, {"Citation": "Kingston D. Modern natural products drug discovery and its relevance to biodiversity conservation. J. Nat. Prod. 2011;74:496\u2013511.", "ArticleIdList": ["PMC3061248", "21138324"]}, {"Citation": "Chianese G. Antiplasmodial triterpenoids from the fruits of neem, Azadirachta indica. J. Nat. Prod. 2010;73:1448\u20131452.", "ArticleIdList": ["20669933"]}, {"Citation": "Murthy K.N.C. Obacunone and obacunone glucoside inhibit human colon cancer (SW480) cells by the induction of apoptosis. Food Chem. Toxicol. 2011;49:1616\u20131625.", "ArticleIdList": ["21515332"]}, {"Citation": "Jin Z. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature. 2020;582:289\u2013293.", "ArticleIdList": ["32272481"]}, {"Citation": "Baez-Santos Y. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus. J. Virol. 2014;88:12511\u201312527.", "ArticleIdList": ["PMC4248884", "25142582"]}, {"Citation": "B\u00e1ez-Santos Y.M. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Antiviral Res. 2015;115:21\u201338.", "ArticleIdList": ["PMC5896749", "25554382"]}, {"Citation": "Barretto N. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J. Virol. 2005;79:15189\u201315198.", "ArticleIdList": ["PMC1316023", "16306590"]}, {"Citation": "Kirchdoerfer R. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat. Commun. 2019;10:2342.", "ArticleIdList": ["PMC6538669", "31138817"]}, {"Citation": "Gao Y. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779\u2013782.", "ArticleIdList": ["PMC7164392", "32277040"]}, {"Citation": "Letko M. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 2020;5:562\u2013569.", "ArticleIdList": ["PMC7095430", "32094589"]}, {"Citation": "Yuan M. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science. 2020;368:630\u2013633.", "ArticleIdList": ["PMC7164391", "32245784"]}, {"Citation": "Rodell C. An ACE therapy for COVID-19. Sci. Trans. Med. 2020;12:541."}, {"Citation": "Wu K. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc. Natl. Acad. Sci. 2009;106:19970\u201319974.", "ArticleIdList": ["PMC2785276", "19901337"]}]}], "History": [{"Year": "2020", "Month": "5", "Day": "22"}, {"Year": "2020", "Month": "7", "Day": "26"}, {"Year": "2020", "Month": "7", "Day": "26"}, {"Year": "2020", "Month": "8", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "9", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32738628", "PMC7386496", "10.1016/j.compbiomed.2020.103936", "S0010-4825(20)30272-9"]}}]}